Haelakwon Inc
⚠️ Moderate Risk
FEI: 3008526026 • Chungcheongnamdo • SOUTH KOREA
FEI Number
3008526026
Location
Chungcheongnamdo
Country
SOUTH KOREAAddress
217-2 Seondori Seocheongun, , Chungcheongnamdo, , South Korea
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
INSANITARY
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to have been prepared, packed, or held under insanitary conditions whereby it may have become contaminated with filth, or whereby it may have been rendered injurious to health.
Refusal History
Frequently Asked Questions
What is Haelakwon Inc's FDA import refusal history?
Haelakwon Inc (FEI: 3008526026) has 2 FDA import refusal record(s) in our database, spanning from 11/19/2010 to 11/19/2010.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Haelakwon Inc's FEI number is 3008526026.
What types of violations has Haelakwon Inc received?
Haelakwon Inc has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Haelakwon Inc come from?
All FDA import refusal data for Haelakwon Inc is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.